QT
CCCC icon

Quantbot Technologies’s C4 Therapeutics CCCC Stock Holding History

Quantbot Technologies’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,300
Closed -$84.2K – 1484
2024
Q1 		$84.2K Buy
+10,300
New +$79.8K ﹤0.01% 1234
2023
Q4 		– Sell
-5,796
Closed -$10.8K – 1608
2023
Q3 		$10.8K Sell
5,796
-9,523
-62% -$29K ﹤0.01% 1404
2023
Q2 		$42.1K Buy
15,319
+11,800
+335% +$37.9K ﹤0.01% 1340
2023
Q1 		$11.1K Sell
3,519
-1,574
-31% -$9.27K ﹤0.01% 1407
2022
Q4 		$30K Buy
+5,093
New +$42.2K ﹤0.01% 1389
2022
Q1 		– Sell
-1,700
Closed -$54K – 1674
2021
Q4 		$54K Sell
1,700
-2,000
-54% -$79.1K ﹤0.01% 1004
2021
Q3 		$165K Buy
+3,700
New +$158K 0.01% 848

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantbot Technologies's CCCC Position: Q2 2024 in Review

Quantbot Technologies sold out of C4 Therapeutics (CCCC) in Q2 2024, closing a stake of 10,300 shares — an estimated $84.2K sold.

Quantbot Technologies first reported a position in CCCC in Q3 2021 and held it in 7 quarters. The position peaked at $165K in Q3 2021. 115 funds tracked by Wall St. Rank hold CCCC as of Q2 2024.

  • Quantbot Technologies reported no remaining C4 Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Quantbot Technologies sold 10,300 C4 Therapeutics shares in Q2 2024, an estimated $84.2K.
  • Quantbot Technologies first reported a position in C4 Therapeutics in Q3 2021 and held it in 7 quarters.
  • Quantbot Technologies's C4 Therapeutics position peaked at $165K in Q3 2021.
  • 115 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.